Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, resulting in major global public health concerns. The HCV …

Hepatitis C virus (HCV) infection is a major public health burden in Europe, causing an
increasing level of liver-related morbidity and mortality, characterized by several regional …

Background: One of the five strategic directions in the World Health Organization global
health sector strategy on viral hepatitis 2016–2021 is to generate strong strategic …

Today, with the introduction of interferon-free direct-acting antivirals and outstanding
progresses in the prevention, diagnosis and treatment of hepatitis C virus (HCV) infection …

Epidemiology of Hepatitis C Page 1 REVIEW 140 |CliniCal liver Disease, vOl 12, nO 5,
nOveMBer 2018 An Official Learning Resource of AASLD epidemiology of Hepatitis C Syed-Mohammed …

Natural resistance-associated substitutions (RASs) are reported with highly variable
prevalence across different HCV genotypes (GTs). Frequency of natural RASs in a large …

We report the largest study on the prevalence and distribution of HCV genotypes in Spain
(2000‐2015), and we relate them with clinical, epidemiological and virological factors …

[1] Hezode C, Chevaliez S, Scoazec G, Soulier A, Varaut A, Bouvier-Alias M, et al.
Retreatment with sofosbuvir and simeprevir of patients with hepatitis C virus genotype 1 or 4 …

Chronic hepatitis C is curable disease. Low detection rate could be one of the reasons of
poor treatment uptake. It is important to identify HCV prevalence and anti-hepatitis C virus …

Any successful strategy to prevent and control HCV infection requires an understanding of
the epidemic behaviour among the different genotypes. Here, we performed the first …